HR Pharma has filed for a prescription to OTC switch for Opill, a decades-old daily progestin-only pill, just a few weeks after its $2 billion takeover by Ireland-headquartered Perrigo was completed.

to manufacture and market a generic version of Merck 's anti-Covid pill Molnupiravir in India. Sun Pharma will launch Molnupiravir under the brand name Molxvir in India, within a week, the company ...